Zeronda Tyler 4
4 · VYNE Therapeutics Inc. · Filed Apr 4, 2023
Insider Transaction Report
Form 4
Zeronda Tyler
CHIEF FINANCIAL OFFICER
Transactions
- Tax Payment
Common Stock
2023-03-31$3.08/sh−384$1,183→ 8,108 total
Footnotes (2)
- [F1]Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.
- [F2]On February 10, 2023, the Issuer effected a one-for-18 reverse split of its Common Stock. The number of securities reported reflects the reverse split.